Salute e Benessere
Fujitsu and Acer Medical trial AI service that assesses future disease risk in elderly patients through gait pattern abnormality detection
Under the business model Fujitsu Uvance, Fujitsu is building an ecosystem of Uvance Partners that will apply data and AI towards the resolution of social issues. Through co-creation with these partners, and utilizing AI Decision Intelligence, Fujitsu aims to realize high-end health management services and advance people's wellbeing.
Under this partnership, Fujitsu and Acer Medical will accelerate efforts to address the social challenges related to gait abnormalities, including their presentation as the early symptoms of dementia and Parkinson's disease. The two companies aim to improve access to elderly care by rolling out this jointly-developed solution to care facilities and primary care clinics in Taiwan and hope to eventually apply it in sports science analysis, pediatric neurodevelopmental disorders, and cerebral palsy.
For full release click here
View original content:https://www.prnewswire.co.uk/news-releases/fujitsu-and-acer-medical-trial-ai-service-that-assesses-future-disease-risk-in-elderly-patients-through-gait-pattern-abnormality-detection-302506293.html